enVVeno Medical Corporation

NVNONASDAQ · Surgical & Medical Instruments & Apparatus

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

673K

on 2026-06-30, from 381K on 2024-03-31 10-Q ↗

Earlier counts are adjusted for the 1-for-35 reverse split; each bar's tip shows the count as filed.

Newest

$100.0M

S-3 of 2026-08-21. None sold under it to 2026-10-05. S-3 ↗

$50.0M

Ladenburg Thalmann, agreement of 2025-10-30. No at-the-market sales statement read from a 10-Q or 10-K. 424B5 ↗

Warrants

The 10-Q filed 2026-07-30 is not read yet.

Cash

5.9 quarters

$21.5M on 2026-06-30 ÷ $3.7M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised: 4 of its filings are not read yet.

Also on file: a 1-for-35 reverse split, 2026-01-20 8-K ↗